Rocket


Overview
Financials
News + Filings





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

QLY Biotech Group Corp.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsAug-31-22Aug-31-21Aug-31-20
   10-K10-K10-K
Revenues  0.00.00.0
            Revenue growth  -100.0%0.0% 
Cost of goods sold  0.00.00.0
Gross profit  0.00.00.0
            Gross margin   65.0%65.0%
Selling, general and administrative   [+]0.00.00.0
Other operating expenses   0.00.0
EBITDA   [+]  0.0
            EBITDA margin   -667.6%-295.7%
Depreciation  0.00.00.0
EBITA  0.00.00.0
            EBITA margin   -627.6%-298.3%
Amortization of intangibles  0.00.00.0
EBIT   [+]0.00.00.0
            EBIT margin   -667.6%-331.6%
Other income (expense), net   0.00.0
Pre-tax income  0.00.00.0
Income taxes  0.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income  0.00.00.0
            Net margin   -737.6%-133.3%
   
Basic EPS   [+]$0.00($0.01)$0.00
Diluted EPS   [+]$0.00($0.01)$0.00
   
Shares outstanding (basic)   [+]3.93.93.1
Shares outstanding (diluted)   [+]3.93.93.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy